Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
October 8, 2008

Pharmacells Obtains Access to Moraga’s Blood-Derived Blastomere-Like Stem Cells

  • Moraga Biotechnology licensed its blood-derived blastomere-like stem cells (BLSCs) to Pharmacells. The goal is to progress and introduce BLSCs as a new and better way to research and use adult stem cells.

    This agreement immediately advances Moraga’s technology into the U.K. and Ireland and provides a platform for further expansion in the EU. Pharmacells will use Moraga’s adult stem cell technology for banking BLSCs that have been isolated, processed, and cryopreserved.

  • Finally! A cure for the Biotech News Blues.

  • Join 110,000 colleagues who rely on GEN Highlights for breaking news and exclusive articles shaping today’s life science tools and technologies.

  • Oops! Please type your email in the following format: yourname@example.com An error has occurred. Please contact Customer Service at contactGEN@genengnews.com
  • You’re all set! Thank you for subscribing to GEN Highlights.